Lindbrook Capital’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-121
Closed -$4K 2244
2021
Q3
$4K Buy
121
+73
+152% +$2.2K ﹤0.01% 1365
2021
Q2
$1K Sell
48
-16
-25% -$499 ﹤0.01% 1881
2021
Q1
$2K Buy
+64
New +$2.15K ﹤0.01% 1642

Other funds holding ZEAL

Lindbrook Capital's ZEAL Position: Q4 2021 in Review

Lindbrook Capital sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q4 2021, closing a stake of 121 shares — an estimated $4K sold.

Lindbrook Capital first reported a position in ZEAL in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 12 funds tracked by Wall St. Rank hold ZEAL as of Q4 2021.

  • Lindbrook Capital reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Lindbrook Capital sold 121 Zealand Pharma A/S American Depositary Shares shares in Q4 2021, an estimated $4K.
  • Lindbrook Capital first reported a position in Zealand Pharma A/S American Depositary Shares in Q1 2021 and held it in 3 quarters.
  • Lindbrook Capital's Zealand Pharma A/S American Depositary Shares position peaked at $4K in Q3 2021.
  • 12 funds tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q4 2021.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.